Nerve-sparing radical hysterectomy: Local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA

International Journal of Gynecological Cancer

Volumn 19, Issue 1, 2009, Pages 39-45

  Van Den Tillaart, Sabrina A H M ^a   Kenter, Gemma G ^a   Peters, Alexander A W ^a   Dekker, Friedo W ^b   Gaarenstroom, Katja N ^a   Fleuren, Gertjan J ^a   Trimbos, J Baptist M Z ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Clinical Epidemiology ^*  (Netherlands)

Author keywords

Nerve sparing; Radical hysterectomy; Uterine cervical neoplasms

Indexed keywords

PLATINUM DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; NERVE SPARING RADICAL HYSTERECTOMY; OPERATION DURATION; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; ADENOCARCINOMA; COMPARATIVE STUDY; FOLLOW UP; HYSTERECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 65649088656     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e318197f675     Document Type: Article

References (36)

1. Maas CP, Trimbos JB, Deruiter MC, et al. Nerve sparing radical hysterectomy: latest developments and historical perspective. Crit Rev Oncol Hematol. 2003;48(3):271-279.
2. Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340(18):1383-1389.
3. Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16(3):1130-1139.
4. Pieterse QD, Maas CP, ter Kuile MM, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006;16(3):1119-1129.
5. Jensen PT, Groenvold M, Klee MC, et al. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer. 2004;100(1):97-106.
6. Axelsen SM, Petersen LK. Urogynaecological dysfunction after radical hysterectomy. Eur J Surg Oncol. 2006;32(4):445-449.
7. Maas CP, Ter Kuile MM, Laan E, et al. Objective assessment of sexual arousal in women with a history of hysterectomy. BJOG. 2004; 111(5):456-462.
8. Chen GD, Lin LY, Wang PH, et al. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol. 2002;85(2): 292-297.
9. Butler-Manuel SA, Summerville K, Ford A, et al. Self-assessment of morbidity following radical hysterectomy for cervical cancer. J Obstet Gynaecol. 1999;19(2):180-183.
10. Pieterse QD, Ter Kuile MM, Deruiter MC, et al. Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report. Int J Gynecol Cancer. 2007.
11. Todo Y, Kuwabara M, Watari H, et al. Urodynamic study on postsurgical bladder function in cervical cancer treated with systematic nerve-sparing radical hysterectomy. Int J Gynecol Cancer. 2006;16(1):369-375.
12. Sakuragi N, Todo Y, Kudo M, et al. A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function. Int J Gynecol Cancer. 2005;15(2): 389-397.
13. Papp Z, Csapo Z, Hupuczi P, et al. Nerve-sparing radical hysterectomy for stage IA2-IIB cervical cancer: 5-year survival of 501 consecutive cases. Eur J Gynaecol Oncol. 2006;27(6):553-560.
14. Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer. 2000;88(10):2267-2274.
15. Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62(1):19-24.
16. Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34(2):206-211.
17. Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84(1):145-149.
18. Kinney WK, Hodge DO, Egorshin EV, et al. Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol. 1995;57(1):3-6.
19. DiSaia PJ. Surgical aspects of cervical carcinoma. Cancer. 1981; 48(Suppl 2):548-559.
20. Shingleton HM. Surgery for cervical cancer: a time for reassessment. Gynecol Oncol. 1998;69(1):8-13.
21. Landoni F, Bocciolone L, Perego P, et al. Cancer of the cervix, FIGO stages IB and IIA: patterns of local growth and paracervical extension. Int J Gynecol Cancer. 1995;5(5):329-334.
22. Barton DP, Butler-Manuel SA, Buttery LD, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2002;12(3):319.
23. Jackson KS, Naik R. Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer. 2006;16(1):354-363.
24. Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001;11(3):180-186.
25. Hagen B, Shepherd JH, Jacobs IJ. Parametrial resection for invasive cervical cancer. Int J Gynecol Cancer. 2000;10(1):1-6.
26. Trimbos JB, Hellebrekers BW, Kenter GG, et al. The long learning curve of gynaecological cancer surgery: an argument for centralisation. BJOG. 2000;107(1):19-23.
27. Samlal RA, Van der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8(1):78-84.
28. Look KY, Rocereto TF. Relapse patterns in FIGO stage IB carcinoma of the cervix. Gynecol Oncol. 1990;38(1):114-120.
29. Krebs HB, Helmkamp BF, Sevin BU, et al. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol. 1982;59(4):422-427.
30. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet. 1997;350(9077):535-540.
31. Larson DM, Copeland LJ, Stringer CA, et al. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol. 1988;30(3): 381-387.
32. Trimbos JB, Franchi M, Zanaboni F, et al. 'State of the art' of radical hysterectomy; current practice in European oncology centres. Eur J Cancer. 2004;40(3):375-378.
33. Hockel M, Dornhofer N. The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection. Cancer Res. 2005;65(8):2997-3002.
34. Einenkel J, Vinkurova S, Ziegert C, et al. Occult local tumor spread in cervical cancer patients. Int J Gynecol Cancer. 2004; 14(suppl 1):35.
35. Hockel M, Horn LC, Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol. 2005;6(10):751-756.
36. Hockel M. Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology. Gynecol Oncol. 2007.